Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan Biomaterial Revenue

In the year 2025, Taiwan Biomaterial had annual revenue of 220.40M TWD with 128.22% growth. Taiwan Biomaterial had revenue of 46.20M in the quarter ending December 31, 2025, with 58.92% growth.

• Revenue: 220.40M
• Revenue Growth: +128.22%
• P/S Ratio: 8.59
• Revenue / Employee: 6.30M
• Employees: 35
• Market Cap: 1.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	220.40M	123.83M	128.22%
Dec 31, 2024	96.57M	23.74M	32.59%
Dec 31, 2023	72.84M	-54.47M	-42.79%
Dec 31, 2022	127.31M	85.63M	205.48%
Dec 31, 2021	41.67M	23.60M	130.56%